Press Releases Investor Overview Press Releases Events and Presentations Upcoming Events Past Events Presentations Analyst Coverage SEC Filings Stock Information Stock Quote & Chart Historical Price Lookup Investment Calculator Corporate Governance Governance Overview Management Board of Directors Committee Composition Information Request Investor Overview Press Releases Events and Presentations Upcoming Events Past Events Presentations Analyst Coverage SEC Filings Stock Information Stock Quote & Chart Historical Price Lookup Investment Calculator Corporate Governance Governance Overview Management Board of Directors Committee Composition Information Request Year None2023202220212020 May 6, 2021 Protara Therapeutics Announces First Quarter 2021 Financial Results and Business Overview April 23, 2021 Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations April 19, 2021 Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 19, 2021 Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer March 11, 2021 Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview March 10, 2021 Protara Therapeutics to Participate in the Oppenheimer 31st Annual Healthcare Conference February 4, 2021 Protara Therapeutics to Present at Upcoming Virtual Investor Conferences February 2, 2021 Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors February 2, 2021 Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 7, 2020 Protara Therapeutics Announces Promotion of Jacqueline Zummo, Ph.D., to Chief Scientific Operations Officer December 3, 2020 Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 24, 2020 Protara Therapeutics to Present at Upcoming Virtual Investor Conferences Pagination First page « Previous page ‹ Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Next page › Last page » Displaying 37 - 48 of 67 Print Print Email Alerts Email Alerts RSS Feeds RSS Feeds Email Page Email Page
Year None2023202220212020 May 6, 2021 Protara Therapeutics Announces First Quarter 2021 Financial Results and Business Overview April 23, 2021 Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations April 19, 2021 Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 19, 2021 Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer March 11, 2021 Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview March 10, 2021 Protara Therapeutics to Participate in the Oppenheimer 31st Annual Healthcare Conference February 4, 2021 Protara Therapeutics to Present at Upcoming Virtual Investor Conferences February 2, 2021 Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors February 2, 2021 Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 7, 2020 Protara Therapeutics Announces Promotion of Jacqueline Zummo, Ph.D., to Chief Scientific Operations Officer December 3, 2020 Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 24, 2020 Protara Therapeutics to Present at Upcoming Virtual Investor Conferences Pagination First page « Previous page ‹ Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Next page › Last page » Displaying 37 - 48 of 67
May 6, 2021 Protara Therapeutics Announces First Quarter 2021 Financial Results and Business Overview
April 23, 2021 Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations
April 19, 2021 Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 19, 2021 Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer
March 11, 2021 Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview
March 10, 2021 Protara Therapeutics to Participate in the Oppenheimer 31st Annual Healthcare Conference
February 2, 2021 Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 7, 2020 Protara Therapeutics Announces Promotion of Jacqueline Zummo, Ph.D., to Chief Scientific Operations Officer
December 3, 2020 Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
